By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > The Metastasis Curve: Unexpected Data on Cancer Spread Across Life Stages

The Metastasis Curve: Unexpected Data on Cancer Spread Across Life Stages

GMJ
Last updated: 24/06/2026 00:07
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Scientific illustration showing age-related cancer spread patterns across different life stages
New research reveals that melanoma spreads most in middle-aged mice, not elderly ones as expected. Special immune cells that keep cancer dormant may explain this unexpected protective effect in very old age. — Photo: Angiola Harry / Pexels
SHARE
1 min read|117 words

Recent research presents striking statistical evidence that challenges conventional cancer biology. Analysis of melanoma progression revealed a distinct three-phase pattern: cancer spread was lowest in young mice, surged dramatically in middle-aged mice, then dropped significantly in very old mice. This non-linear progression defies the widely accepted assumption that cancer risk increases steadily with advancing age.

The data suggests that middle age represents a critical vulnerability window for melanoma metastasis. Rather than aging being universally protective or harmful, the relationship appears highly stage-dependent. These findings underscore the need for age-stratified clinical approaches and warrant further investigation into the immune mechanisms that may explain the protective phenomenon observed in extreme old age.

Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: Cancer Spreads More in Middle Age Than in Very Old Age, Melanoma Study Shows →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Rural Healthcare’s $50 Billion Question: Can Technology Alone Solve Workforce Shortages?

A $50 billion US rural healthcare investment prioritises technology infrastructure, but health…

FDA-Approved Drug Restores Immunotherapy Efficacy in Rare Liver Cancer by Releasing Trapped T Cells

Researchers have identified that rare liver cancers evade immunotherapy by trapping immune…

Timing of Second Stent Placement After Heart Attack: New Trial Challenges Immediate Intervention Strategy

A randomized controlled trial published in the New England Journal of Medicine…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Global HealthPolicy & Systems

PAHO activates Ebola preparedness protocols across Americas following Africa outbreak

By
Prof. Giorgi Pkhakadze
07/06/2026
Scientific illustration showing CD4+ T cells attacking MHC I-deficient cancer cells

70% of Advanced Cancers Employ Immune Evasion Strategy with Hidden Weakness

By
Prof. Giorgi Pkhakadze
25/06/2026
Researcher using precision equipment to slice tumor tissue samples for cancer analysis

Virginia Tech Advances Cancer Research Through Precision Tumor Tissue Analysis

By
Prof. Giorgi Pkhakadze
03/06/2026
Medical illustration showing healthy liver cells versus fatty liver cells with ION224 treatment mechanism

115 Million MASH Patients May Benefit from Targeted Drug Therapy

By
Prof. Giorgi Pkhakadze
22/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up